280 related articles for article (PubMed ID: 31401413)
1. The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma.
Sun G; Zhang X; Liu Z; Zhu S; Shen P; Zhang H; Zhang M; Chen N; Zhao J; Chen J; Liu J; Dai J; Wang Z; Zhu X; Wang Y; Zeng H
Neoplasia; 2019 Sep; 21(9):921-931. PubMed ID: 31401413
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses.
Tian L; Luo N; Zhu X; Chung BH; Garvey WT; Fu Y
Atherosclerosis; 2012 Mar; 221(1):66-75. PubMed ID: 22227293
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J
BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889
[TBL] [Abstract][Full Text] [Related]
4. Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression.
Kleinmann N; Duivenvoorden WC; Hopmans SN; Beatty LK; Qiao S; Gallino D; Lhotak S; Daya D; Paschos A; Austin RC; Pinthus JH
Clin Exp Metastasis; 2014 Feb; 31(2):169-83. PubMed ID: 24096711
[TBL] [Abstract][Full Text] [Related]
5. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
D'Costa NM; Lowerison MR; Raven PA; Tan Z; Roberts ME; Shrestha R; Urban MW; Monjaras-Avila CU; Oo HZ; Hurtado-Coll A; Chavez-Munoz C; So AI
J Exp Clin Cancer Res; 2020 Feb; 39(1):33. PubMed ID: 32041631
[TBL] [Abstract][Full Text] [Related]
6. Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma.
Ruan H; Li S; Bao L; Zhang X
Oncogene; 2020 Sep; 39(38):6113-6128. PubMed ID: 32814829
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin receptor expression in human malignant tissues.
Chou SH; Tseleni-Balafouta S; Moon HS; Chamberland JP; Liu X; Kavantzas N; Mantzoros CS
Horm Cancer; 2010 Jun; 1(3):136-45. PubMed ID: 21761356
[TBL] [Abstract][Full Text] [Related]
8. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC
J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.
Chen S; Liu W; Wang K; Fan Y; Chen J; Ma J; Wang X; He D; Zeng J; Li L
PLoS One; 2017; 12(3):e0173725. PubMed ID: 28288190
[TBL] [Abstract][Full Text] [Related]
10. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma.
Zhu Y; Xu L; Zhang J; Xu W; Liu Y; Yin H; Lv T; An H; Liu L; He H; Zhang H; Liu J; Xu J; Lin Z
Cancer Sci; 2013 Jun; 104(6):663-71. PubMed ID: 23433103
[TBL] [Abstract][Full Text] [Related]
11. Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor.
Cai W; Wang Z; Cai B; Yuan Y; Kong W; Zhang J; Chen Y; Liu Q; Huang Y; Huang J; Xue W
Int J Clin Oncol; 2020 Feb; 25(2):338-346. PubMed ID: 31720994
[TBL] [Abstract][Full Text] [Related]
12. Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma.
Cheng SP; Liu CL; Hsu YC; Chang YC; Huang SY; Lee JJ
Cell Biochem Biophys; 2013 Mar; 65(2):203-10. PubMed ID: 22907586
[TBL] [Abstract][Full Text] [Related]
13. SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway.
Li XL; Chen XQ; Zhang MN; Chen N; Nie L; Xu M; Gong J; Shen PF; Su ZZ; Weng X; Tan JY; Zhao T; Zeng H; Zhou Q
Int J Clin Exp Pathol; 2015; 8(4):3871-81. PubMed ID: 26097571
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
[No Abstract] [Full Text] [Related]
15. Expression of adiponectin and its receptors is altered in epithelial ovarian tumors and ascites-derived ovarian cancer cell lines.
Tiwari A; Ocon-Grove OM; Hadley JA; Giles JR; Johnson PA; Ramachandran R
Int J Gynecol Cancer; 2015 Mar; 25(3):399-406. PubMed ID: 25700032
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 induces drug resistance in renal cell carcinoma.
Ishibashi K; Koguchi T; Matsuoka K; Onagi A; Tanji R; Takinami-Honda R; Hoshi S; Onoda M; Kurimura Y; Hata J; Sato Y; Kataoka M; Ogawsa S; Haga N; Kojima Y
Fukushima J Med Sci; 2018 Dec; 64(3):103-110. PubMed ID: 30369518
[TBL] [Abstract][Full Text] [Related]
17. CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.
Sekino Y; Takemoto K; Murata D; Babasaki T; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Taniyama D; Shigeta M; Kuraoka K; Mita K; Kaneko M; Sentani K; Oue N; Teishima J
Anticancer Res; 2021 Oct; 41(10):4875-4883. PubMed ID: 34593435
[TBL] [Abstract][Full Text] [Related]
18. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway.
Lin Y; Yang Z; Xu A; Dong P; Huang Y; Liu H; Li F; Wang H; Xu Q; Wang Y; Sun D; Zou Y; Zou X; Wang Y; Zhang D; Liu H; Wu X; Zhang M; Fu Y; Cai Z; Liu C; Wu S
Sci Rep; 2015 Mar; 5():8997. PubMed ID: 25757764
[TBL] [Abstract][Full Text] [Related]
19. Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway.
Cui XB; Wang C; Li L; Fan D; Zhou Y; Wu D; Cui QH; Fu FY; Wu LL
Cardiovasc Res; 2012 Jan; 93(1):69-78. PubMed ID: 22012952
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
